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A Critical Role for Amino-Terminal
Glutamine/Asparagine Repeats in the Formation
and Propagation of a Yeast Prion
intervals, leading to a characteristic red-green birefrin-
gence under polarized light. Despite these shared struc-
tural features, electron microscopy (EM) and atomic
force microscopy (AFM) (Harper et al., 1997a) analyses
indicate that there are ultrastructural variations (e.g.,
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differences in the number and packing of the protofila-San Francisco, California 94143-0450
ments) between the amyloids. It is also possible that
individual protein monomers retain partial native struc-
ture within the amyloid (Liu et al., 1998).
Summary To date, z20 proteins have been found to form amy-
loids associated with human disease. These include the
mammalian prion protein, PrP, the infectious proteinThe yeast [PSI1] factor propagates by a prion-like
implicated as the causative agent of transmissible spon-mechanism involving self-replicating Sup35p amyloids.
giform encephalopathies (see Caughey and Chesebro,We identified multiple Sup35p mutants that either are
1997; Prusiner et al, 1998). PrP forms amyloid fibrils that,poorly recruited into, or cause curing of, wildtype amy-
at least under some conditions, are associated with theloids in vivo. In vitro, these mutants showed markedly
infectious agent.Similarly, some non-prion neurodegen-decreased rates of amyloid formation, strongly sup-
erative diseases, such as Alzheimer's and Huntington'sporting theprotein-only prion hypothesis. Kinetic anal-
disease, also involveamyloid formation. In Huntington's,ysis suggests that the prion state replicates by accel-
as well as several other neurodegenerative diseases,erating slow conformational changes rather than by
amyloid formation appears to be caused by expansionproviding stable nuclei. Strikingly, our mutations map
of a polyglutamine (polyGln) tract (e.g., Paulson et al.,exclusively within a short glutamine/asparagine-rich
1997; Scherzinger et al., 1997). Finally, systemic amy-region of Sup35p, and all but one occur at polar resi-
loidoses result from the aggregation of a number ofdues. Even after replacement of this region with poly-
proteins such as lysozyme and transthyretin (TTR) (Wet-glutamine, Sup35p retains its ability to form amyloids.
zel, 1997).These and other considerations suggest similarities
Despite active research, many basic questions aboutbetween the prion-like propagation of [PSI1] and poly-
the conversion from native state to amyloid fibril remainglutamine-mediated pathogenesisof several neurode-
unanswered. For example, little is known about whatgenerative diseases.
stabilizes amyloid structures. In particular, how sensitive
is amyloid formation to changes in primary sequence?
Introduction Are amyloids, like amorphous aggregates, principally
stabilized by hydrophobic interactions? The mechanism
Virtually all denatured proteins have a strong propensity of propagation of infectious prion diseases and its rela-
to form amorphous aggregates. This aggregation is tionship to that of noninfectious amyloidoses is also
largely driven by the association of hydrophobic regions poorly understood (Harper and Lansbury, 1997; Prusiner
that are normally buried in the native structure (for re- et al., 1998). For example, what is the nature of the rate-
view, see Jaenicke and Seckler, 1997). In contrast to limiting step in de novo formation of amyloids, and how
these more frequent disordered aggregates, some pro- do preformed fibrils accelerate this process? Lastly, our
teins form ordered aggregates called amyloid fibrils. understanding of the role of cellular factors, such as
Amyloidogenic proteinsshow noobvious sequence sim- molecular chaperones, in promoting formation of amy-
ilarity, nor do their native folds resemble one another. loids is incomplete (Chernoff et al., 1995; Kaneko et
Yet despite this diversity amyloid fibrils appear to share al., 1997). In particular, do in vitro conversion reactions
a similar architecture. using purified proteins accurately reproduce the propa-
Amyloid fibrils are cross b-sheet structures in which gation of disease or infection in vivo?
the individual b strands run perpendicular to the long The prion-like phenomenon [PSI1] of the yeast Sac-
axis of the fibril, whereas the faces of the b sheetsextend charomyces cerevisiae provides a powerful model sys-
parallel to it (Lansbury et al., 1995; Sunde and Blake, tem to address these questions. [PSI1] is a non-Mende-
1997). These fibrils are roughly 100 AÊ in diameter and are lian trait that causes suppressionof nonsense mutations
typically composed of 4±6 interwoven protofilaments. (Cox et al., 1988). This nonsense suppression is thought
to result from the conversion of the translation termina-Recent X-ray diffraction studies suggest that the b
tion factor Sup35p from a soluble and functional statesheets composing the individual protofilaments are
into insoluble and inactive amyloid fibrils (Wickner et al.,twisted, resulting in a helical conformation propagating
1995; see Lindquist, 1997). [PSI1] appears to propagatealong the amyloid axis (Sunde et al., 1997; see, however,
by a prion-like mechanism in which the amyloid form ofLazo and Downing, 1998). The ordered structure of amy-
Sup35p promotes the conversion of newly made solubleloids allows them to bind the dye Congo red at regular
Sup35p to insoluble fibrils. The increased nonsense sup-
pression caused by the [PSI1] factor can be readily mon-
itored by using a strain carrying a marker gene with a³To whom correspondence should be addressed.
§These authors contributed equally to this work. nonsense mutation. Thus, the [PSI1] phenomenon allows
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Figure 1. Illustration of the Screen for ASU
and PNM Mutants
(A) Schematic of Sup35p domain structure.
Residue numbers are indicated on the top of
the schematic.
(B) Illustration of the logic underlying the
screen for ASU and PNM mutants. Through-
out the figures, strain backgroundis indicated
by c1 for [PSI1] and by c2 for [psi2]. The
Sup35p alleles present are indicated in the
lower left of each panel and diagramatically
with solid and gray shapes representing WT
Sup35p and mutant Sup35p, respectively.
The phenotypes resulting from expression of
the indicated Sup35p alleles are listed in the
bottom row beneath each panel. Amyloids
are denoted by stacked monomers, and solu-
ble Sup35p are denoted by unattached sub-
units. Two hypothetical mechanisms for PNM
mediated curing are illustrated in the final
panel. These involve either capping of amy-
loids to prevent further monomer addition
(left) or conformational change, which ren-
ders the amyloids uninheritable (right).
(C) Examples of sectored colonies resulting
from expression of ASU and PNM mutants.
The solubilization states of the various alleles
of Sup35p that could lead to the observed
color changes are illustrated on the right of
the colony (see text). Diagrams and symbols
are as in (B).
(D) Sample data demonstrating plasmid-
dependent antisuppresion. Growth of a [PSI1]
strain initially bearing AQ15R on a URA3
marked plasmid on the indicated medium is
shown. [PSI1] and [psi2] expressing WT pro-
tein are shown for comparison.
one to assess the microscopic aggregation state of the function. The C-terminal domain, referred to as EF be-
cause of its homology to elongation factors, encodes aSup35p protein in vivo by examining the macroscopic
properties of a yeast colony. translation termination activity (Stansfield et al., 1995).
Expression of this domain without a PrD provides aHere, we use the [PSI1] system todefine the sequence
requirements for efficient formation and prion-like prop- pool of soluble, active EF domain, resulting in a loss of
nonsense suppression even in cells containingwild-typeagation of Sup35p amyloids in vivo. In addition, using
an in vitro conversion reaction (Glover et al., 1997; King (WT) Sup35p aggregates (Ter-Avanesyan et al., 1993).
Hereafter, [PSI1] refers to the presence of heritable ag-et al., 1997; Paushkin et al., 1997), we have exploited
mutant Sup35p proteins that are defective in amyloid gregates; [PSI1] yeast that also contain soluble EF, and
therefore no longer exhibit nonsense suppression, willformation to help elucidate the mechanism of prion
propagation. be referred to as antisuppressed.
We have developed a genetic screen to identify PrD
mutants that are defective in amyloid formation andResults
propagation. This screen is based on the fact that such
mutants will remain soluble even in a [PSI1] yeast cellMutagenesis of the Sup35p Reveals a Requirement
for Glutamine/Asparagine-Rich Sequences that contains WT Sup35p aggregates, thereby confer-
ring an antisuppressor (ASU) phenotype (Figure 1B). ToSup35p is composed of three domains (Ter-Avanesyan
et al., 1993) (Figure 1A). The N-terminal prion determin- track the suppression phenotype, a [PSI1] strain harbor-
ing a nonsense mutation in the ADE1 gene was useding domain (PrD) is necessary and sufficient for propa-
gation of aggregates. Deletion of this domain allows (Chernoff et al., 1995). In yeast retaining their nonsense
suppression phenotype, functional Ade1p is producedSup35p to remain soluble even in [PSI1] cells (Paushkin
et al., 1996). Conversely, fusion of the PrD to GFP con- resulting in white colonies on complete medium (YPD)
and an ability to grow on medium lacking adenine (SD-fers aggregation of the fusion protein in a [PSI1]-depen-
dent manner (Patino et al., 1996). The middle domain ADE). However, in either [psi2] or antisuppressed yeast,
Ade1p is truncated and nonfunctional, resulting in red(M) of Sup35p is a highly charged region of unknown
Role of Gln/Asn Repeats in a Yeast Prion
1243
Figure 2. Summary of ASU and PNM Mutants
(A) Bar graph of the frequency and phenotype of the PrD mutants as a function of residue position. Amino acid changes from the WT sequence
(x axis) are indicated within the bars. All mutants contain changes within residues 8±24 of the PrD. Double mutants are indicated by a
superscript and contain the following changes: (1) PN9K, Q24R; (2) PQ10R, Q91L; (3) PQ15R, Q33R; (4) PQ24R, N26D, where the mutant is
denoted by the first letter of the phenotype (A or P) followed by the amino acid changes. For double mutants, changes outside of residues
8±24 are not reported when they do not affect the phenotype.
(B) Average glutamine/asparagine content of the PrD as function of residue number. The color indicates the percent of glutamine and asparagine
residues in a window spanning nine amino acids (scale is indicated on the right). The black bar above the graph marks the location of the
isolated PrD mutations.
colonies onYPD and failure to grow on SD-ADE. The PrD expression of PNM mutants ranged from z1%±50% and
generally increased with expression time. We screenedwas uniformly mutagenized using PCR under conditions
that favored single nucleotide changes. A library of z15,000 colonies for ASU phenotypes and z30,000 col-
onies for PNM phenotypes. In this pool, we estimatesup35 genes with mutagenized PrDs was episomally
expressed on a URA3-marked plasmid in a strain that that every point mutant is represented 5- to 10-fold. In
total, 28 ASU and 13 PNM mutants were sequenced.contains chromosomally encoded WT Sup35p.
Yeast expressing compromised PrDs were readily The observed redundancy in recovered alleles is in good
agreement with this estimated overrepresentation (Fig-identified because they formed red/white sectored colo-
nies on YPD (Figure 1C). White sectors result from yeast ure 2A). The individual mutations are denoted by the
first letter of the phenotype (A or P) followed by thethat have lost the plasmid expressing mutant Sup35p
but have retained WT aggregates. Conversely, red sec- amino acid changes.
Unexpectedly, all ASU and PNM mutants containedtors result from either an ASU phenotype caused by the
presence of the mutant Sup35p or conversion to [psi2] changes in a short region at the extreme N terminus of
the PrD between residues 8 and 24 (Figure 2A). The(i.e., permanent loss of all Sup35p aggregates). The ASU
phenotype was confirmed by the lack of functional failure to identify mutations outside of this region was
not due to lack of diversity in the original mutant pool,Ade1p under growth conditions that require retention
of the mutant Sup35p plasmid (i.e., inability to grow on as a number of mutations that did not cause the ASU
phenotype were found throughout the PrD. Nor was itSD-ADE, -URA, Figure 1D). In contrast, the nonsense
suppression phenotype returned following plasmid loss because the residues outside this region were unneces-
sary for PrD function: deletion of residues 53±124 of the(i.e., growth on SD-ADE medium). The ASU mutants
were then examined for their ability to cause permanent PrD resulted in an ASU phenotype (data not shown),
and a previously described chromosomal PNM mutantconversion to a [psi2] state. Such ªcuringº alleles are
referred to as Psi No More (PNM) mutants (Doel et al., maps outside this region (Doel et al., 1994). Rather, it
appears that point mutations outside this region did not1994). Cured yeast were identified by the presence of
red colonies on 5-FOA medium, which selects for yeast result in a sufficiently robust ASU phenotype to pass
our screens. Although the entire PrD has a high Gln/Asnthat have lost the plasmid expressing the mutant
Sup35p. The fraction of cured cells caused by transient content, the subdomain identified by our mutagenesis
Cell
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Figure 3. Aggregation State of Mutant PrD as Assayed by GFP Fluo-
rescence
Yeast expressing a PrD-GFP fusion construct were examined 2 hr
postinduction. Diffuse fluorescence throughout the cytoplasm is
indicative of soluble protein, while bright discrete foci are indicative
of protein associated with prion-like Sup35p aggregates. Larger
aggregates result in a halo of fluorescence, which is not interpreted
as soluble protein. The PSI state and PrD allele are indicated below. Figure 4. Aggregation State of Mutant PrD Alleles as Assayed by
(A) [psi2] yeast expressing WT-PrD-GFP. High Speed Centrifugation
(B) [PSI1] yeast expressing WT-PrD-GFP. Mid±log phase cell extracts were prepared from yeast strains car-
(C) A representative field in which an ASU mutant appears entirely rying a plasmid expressing the indicated allele of Sup35p. Extracts
soluble in presence of WT aggregates ([PSI1] expressing AG20R- were centrifuged at 100,000 g, and soluble (S) or pelleted (P) frac-
PrD-GFP). tions were assayed by Western blot. Plasmid-derived protein was
(D) A representative field in which an ASU mutant appears to associ- distinguished from WT chromosomal Sup35p by the addition of a
ate predominantly with WT aggregates ([PSI1] expressing AQ22R- hemaglutanin (HA3) tag between the M and EF domains (schematic
PrD-GFP). at top). The PSI state of the cells and the expressed mutant protein
(E) Representative fields in which ASU mutants appear to partition allele are indicated above each set of lanes.
between soluble pools and discrete foci ([PSI1] yeast expressing (A) Solubility of WT Sup35p compared to ASU mutant proteins in
AQ15R-PrD-GFP [top] and AN8D-PrD-GFP [bottom]). [PSI1] yeast. For comparison, WT Sup35p in [psi2] yeast is also
shown. Note that the presence of Sup35p in [psi2] pellet is not likely
to represent prion-like Sup35p aggregates, and thus the levels of
shows a particularly strong enrichment for these amino soluble protein are an underestimate of the amount of functional
Sup35p.acids (Figure 2B). Moreover, all of the mutations oc-
(B) Solubility of PNM mutants in [PSI1] yeast.curred in Gln or Asn residues with the exception of a
(C) Solubility of WT Sup35p in [PSI1] yeast coexpressing mutantsingle Gly and a single Ser mutant. Virtually all mutations
PrD alleles. WT Sup35p was tagged with (HA3), while mutant proteinresulted ina change to charged amino acids.Particularly was untagged and therefore not recognized by Western blot. The
striking is the predominance of Gln or Ser to Arg muta- untagged mutant protein present is indicated in parentheses above
tions. This is physically reasonable because the bulky each set of lanes.
and charged Arg side chain is likely to be particularily
disruptive to protein±protein interactions. Gly or Asn to CUP1 promoter. Use of an inducible promoter minimizes
Arg mutations are not observed, however, because they secondary effects that prolonged expression of mutants
would require two nucleotide changes. might have on the solubility of the WT Sup35p. In con-
trast to WT PrD-GFP, which had uniformly punctate pat-
ASU and PNM Mutants Show Diminished terns in [PSI1] cells, each mutant led to a mixed popula-
Ability to Be Recruited into WT Sup35p tion of fluorescent patterns: in individual cells, the fusion
Aggregates In Vivo proteins either appeared entirely soluble (Figure 3C), in
The screen for ASU and PNM mutants was based on discrete foci (Figure 3D), or more commonly in both
the hypothesis that the antisuppression phenotypes re- (Figure 3E).
sulted from a decreased ability of mutant PrDs to be We next examined the aggregationstate of the mutant
recruited into WT Sup35p aggregates. We tested this PrDs using a centrifugation assay that made it possible
using a GFP-based assay described by Lindquist and to determine the solubility of full-length Sup35p protein
coworkers (Patino et al., 1996). WT PrD-GFP converts expressed from its natural promoter (Patino et al., 1996;
from a diffuse fluorescence pattern in [psi2] cells (Figure Paushkin et al., 1996). In [PSI1] cells, Sup35p is in aggre-
3A) to a punctate pattern in [PSI1] (Figure 3B), making gates that are efficiently separated from soluble protein
it possible to monitor the aggregation state of PrD fusion fractions by centrifugation. In contrast, Sup35p in [psi2]
protein in vivo. Each of the ASU and PNM mutants was cells remains predominately soluble following centrifu-
gation (Figure 4A, lanes 1±4). To distinguish mutantfused to GFP and put under control of the inducible
Role of Gln/Asn Repeats in a Yeast Prion
1245
Sup35p from chromosomally encoded WT protein, the
mutant proteins were tagged with the HA antigen. Fol-
lowing centrifugation, levels of soluble and aggregated
proteins were examined by Western blot analysis. We
found that 9 of the 11 ASU and PNM mutants showed
significant increases in soluble protein in [PSI1] cells
(Figures 4A and 4B). As might be expected from its
comparatively weak ASU phenotype, the tagged version
of AN8D showed little, if any, increase in soluble protein
(Figure 4A, lanes 5 and 6). AQ14R was atypical, having
a strong phenotype, yet little soluble protein and de-
creased protein levels (Figure 4A, lanes 7 and 8). We
also examined whether expression of the ASU and PNM
mutants led to solubilization of WT Sup35p in [PSI1]
yeast by coexpressing HA-tagged WT Sup35p and un-
tagged mutant proteins. Though most ASU mutants did
not result in an increase in soluble WT Sup35p, expres-
sion of AS17R led to significant solubilization of WT
protein (Figure 4C, lanes 3 and 4). The PNM mutants
generally caused a modest increase in soluble WT pro-
tein with the strongest effect resulting from expression
of PQ24R (Figure 4C, lanes 5 and 6).
WT Sup35 PrD Rapidly Forms Amyloids
In Vitro in a Reaction that Has Both
Concentration-Dependent
and -Independent Phases
Recently, three groups demonstrated that the PrD do-
main from Sup35p can form self-propagating aggre-
gates in vitro (Glover etal., 1997; King et al., 1997; Paush-
kin et al., 1997), facilitating greatly detailed studies of
the mechanism of fibril formation. Although in all of these
Figure 5. In Vitro Amyloid Fibril Formation of WT Sup35pstudies amyloid formation was preceded by a lag phase
To initiate conversion, concentrated protein in urea was diluted atthat was eliminated by the addition of preformed fibrils,
least 100-fold into buffer C and subjected to continuous slow rota-
there were dramatic differences in the time scale of tion. At the indicated times, theextent of fibril formation was assayed
conversion. In particular, Ter-Avanesyan and coworkers by Congo red (CR) binding. Each time curve was performed at least
(Paushkin et al., 1997) observed that in cell-free extracts three times, unless noted otherwise. Errors larger than the size of
symbols are indicated by bars.undergoing a constant slow rotation, a protein con-
(A) Kinetics of conversion of 2.5 mM WT PrD-M in absence (square)taining the PrD and M domains (PrD2M) was recruited
and presence of 0.7% (wt/wt) (triangle) and 3% (wt/wt) (circle) pre-into preformed aggregates within 2 hr. In contrast, Lind-
formed WT fibril. The kinetics of WT seeded with 3% (wt/wt) fibril
quist and coworkers found that pure PrD-M formedamy- were done in duplicate.
loids slowly: spontaneous conversion took days, and (B) Atomic force micrograph of WT PrD-M amyloids. Examples of
seeded conversion took z20 hr (Glover et al., 1997). a fibrillar ridge (open arrow) are seen in the top right panel. In the
bottom right panel, an amorphous structure from which many fibrilsInitially, we observed that in unrotated reactions pure
emanate (open arrow) and branching fibrils (closed arrow) are high-PrD-M converted slowly even in the presence of pre-
lighted. Scale bars are 1 mm, except for upper right figure (100 nm).formed fibrils, although the conversion reaction was
(C) Effect of concentration on the lag phase (T0) of WT Sup35. T0 iscomplicated by amorphous aggregation and settling of calculated as described in Experimental Procedures.
fibrils during long incubation times.
These difficulties could be minimized by slowly rotat-
ing the samples during the incubation. Rotation also dimensions and general features to those seen by EM
(Glover et al., 1997; King et al., 1997), this analysis re-caused a dramatic increase in the conversion kinetics,
as detected by Congo red binding, with seeded reac- vealed several novel features. For example, we saw fi-
brils containing a prominent z10 nm ridge along thetions going to completion in as little as 45 min and
unseeded reactions within 180 min (Figure 5A). As filament axis as well as branching fibrils and fibrils ema-
nating from globular structures (Figure 5B). Branchingjudged by gel filtration, all of the monomeric starting
material appears to have converted to higher order fibrils were also recently observed in AFM analysis of
b-amyloid protein filaments (Harper et al., 1997b) andoligomeric forms. We also observed structural changes
on this time scale, such as increased b2sheet content could be important for creating new fibrils during amy-
loid propagation.by circular dichroism (data not shown). Finally, EM and
AFM analyses directly confirmed that the conversion The rapid and reproducible kinetics of conversion al-
lowed us to perform quantitative analyses of fibril forma-results in fibril formation (Figure 5B and data not shown).
Although amyloids observed by AFM were similar in tion. The conversion kinetics can be characterized by
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Figure 6. Effects of ASU Mutations on the Ki-
netics of Amyloid Fibril Formation
Amyloid formation was monitored by examin-
ing Congo red (CR) binding as a function of
conversion time. Errors larger than the size
of symbols are indicated by bars.
(A) Comparison of amyloid fibril formation be-
tween a representative ASU mutant (AQ15R)
and WT PrD-M either in the absence (upper
panel) or presence (lower panel) of 0.7 % (wt/
wt) WT fibril.
(B) Summary of the lag phases (T0) in amyloid
formation for the ASU mutants either in the
absence (black bar) or presence (shaded bar)
of 0.7% (wt/wt) WT fibril. Note the failure of
WT fibrils to accelerate conversions of AS17R
and AQ22R.
(C) Conversion kinetics of WT PrD-M in the
presence of 0% (circle), 0.7% (square), and
3% (diamond) (wt/wt) AS17R fibrils.
two terms: a lag time (T0), the time prior to the increase 1993)? Because the seed is oligomeric, the nucleation
model predicts that the lag time will show a strong con-in Congo red binding, and a conversion time (Tc), the
time between initiation of conversion and its completion. centration dependence that approaches zero at high
concentrations. We found that within a range of 1.25±6At 2.5 mM, PrD-M has a lag time of 114 6 4 min and a
conversion time of 53 6 12 min (Figure 5A). To eliminate mM, increasing PrD-M concentration did lead to a mod-
est (z2-fold) decrease in lag time (Figure 5C). Furthercontaminating preformed fibrils, urea-denatured PrD-M
(30 kDa) was passed through a 100 kDa filter prior to increases in PrD-M concentration, however, did not lead
to a further decrease of T0 to below 65 min. Thus, atinitiation of conversion. This filtration step appeared to
be sufficient, as passage through a 50 kDa filter immedi- concentrations above 6 mM, the rate-limiting step in
conversion is unaffected by protein concentration. Im-ately after dilution from denaturant did not affect the
conversion kinetics (data not shown). Addition of in- portantly, the molar fraction of Congo red bound also
did not change significantly over the observed concen-creasing amounts of preformed fibrils accelerated con-
version by decreasing T0 without significantly changing tration range (1.25±12 mM).
Tc. For example, 0.7% (wt/wt) fibrils shortened the T0 to
24 6 1 min, and 3% (wt/wt) fibrils eliminated the lag Purified Mutant ASU Proteins Show Decreased
Rates of Amyloid Formation In Vitrotime completely (Figure 5A).
Using the in vitro assay, we probed the nature of We next examined the kinetics of de novo amyloid for-
mation for the ASU mutants. A representative conver-the rate-limiting step responsible for the lag phase. In
particular, is this lag due to the cooperative formation sion curve of an ASU mutant (AQ15R) reveals a marked
decrease in conversion kinetics compared to WT PrD-Mof an ordered oligomeric nucleus as suggested by the
nucleation-polymerization model (Jarrett and Lansbury, (Figure 6A). As with the other mutants, the slow rate of
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fibril formation of AQ15R was predominantly attributable GRV[polyQ1Gly] was comparable to GRV[2Gly] and
GRV[1Gly], respectively, indicating that replacement ofto an increase in lag time (T0 5 260 6 20 min vs. 114 6
4 min for WT) rather than a change in Tc. A summary of the N-terminal residues not identified by mutagenesis
had little effect on function of the PrD (Figure 7 and dataT0 of all the mutants is shown in Figure 6B. Significantly,
the mutants that showed the lowest solubility in vivo not shown). Intriguingly, GRV(1Gly) retained its ability
to form de novo aggregates, as even at early expression(AN8D and AQ14R) had T0 values comparable to that
of WT protein, whereas the stronger mutants (AS17R, times a small fraction (z1%) of the [psi2] cells showed
a punctate fluorescence pattern. At longer incubationAQ15R, and AG20D) showed significantly larger T0
values. times, this fraction increased to z25%. These aggre-
gates are likely to represent, at least in part, genuineTo simulate amyloid propagation invivo, we examined
the ability of preformed WT PrD-M fibrils to promote the conversion events, as overexpression of either GRV-
GFP fusion in [psi2] cells resulted in a enhanced rate ofconversion of purified ASU mutant proteins. For 4 of the
6 ASU mutants, addition of WT fibrils did accelerate conversion to [PSI1] state. Taken together, these obser-
vations indicate that even after replacement of the N-ter-the conversion kinetics. However, the rate of seeded
conversion was significantly slower for all of the ASU minal Gln/Asn region with a polyGln stretch, the PrD
retained its ability both to form new aggregates and tomutants than for WT (Figure 6B). For example, in the
presence of 0.7% (wt/wt) WT fibrils, the T0 of AQ15R be recruited into existing aggregates.
was 83 6 5 min as compared to 24 6 1 min for WT.
Interestingly, for two of the mutants with the strongest
Discussionin vivo phenotype, AS17R and AQ22R, addition of WT
fibrils did not increase the rate of amyloid formation,
Even though the association of amyloid fibrils with dis-even though AQ22R showed only a modest defect in de
eases has been appreciated for several decades, littlenovo fibril formation. Intringuingly, we also found that
is known about what makes a protein amyloidogenic.AS17R mutant fibrils fail to seed the conversion of WT
The cytoplasmically inherited [PSI1] factor of yeast pro-Sup35p (Figure 6C).
vides a powerful system for studying amyloid formation
in vivo and in vitro. Here, we have exploited the PSI
phenomenon to identify point mutations in the prion-The N-Terminal Region of the PrD Identified
by Mutagenesis Can Be Functionally determining domain (PrD) of Sup35p that are defective
in amyloid formation and propagation. This work differsReplaced with PolyGln
Gln and Asn residues are chemically similar, differing fundamentally from previous genetic studiesof mamma-
lian amyloid disorders that have relied on identificationsolely by a single carbon atom separating the carboxy-
amide group from the backbone. Although the Ser side of naturally occurring mutations which accelerate dis-
ease. Such mutations typically increase the propensitychain does not have a hydrogen bond acceptor like
a carboxyamide side chain, it is a polar group with a to form amyloids by destabilizing the native state and
thus do not report directly on the requirements for amy-hydrogen bond donor.To test the functional equivalence
of these side chains, we made a series of glutamine loid formation (Kelly et al., 1997; Wetzel, 1997).
The mutants that we have identified allowed us both toreplacement variants (GRV) of the Sup35p PrD (Figure
7). In the first set of variants, termed GRV(1Gly) and define the sequence requirements for Sup35p amyloid
formation in vivo and to test the relevance of in vitroGRV(2Gly), all of the residues in the N-terminal region
of the PrD that were identified by mutagenesis, either conversion reactions. Two classes of mutants that lead
to increased levels of soluble protein were identified:including or not including the single Gly, respectively,
were replaced with Gln. A second set of variants, termed the first (ASU) inhibited incorporation into aggregates
without irreversibly preventing propagation of WT amy-GRV(polyQ1Gly) and GRV(polyQ-Gly) were made in
which all of the residues (amino acids 8±24) in the loids, and the second (PNM) resulted in curing of the
[PSI1] state in addition to its ASU phenotype. In vitroN-terminal region, either including or not including the
single Gly, were replaced with Gln. These domains were conversion reactions using pure ASU-PrD proteins indi-
cate that the increased solubility of these mutants isfused to GFP and put under the control of the CUP1
promoter. caused directly by a defect in recruitment of soluble
protein by WT prion-like amyloids. We are currently in-We examined the aggregation state of the GRV-GFP
fusion proteins in [PSI1] or [psi2] yeast as a function of vestigating the molecular basis of the curing by the PNM
mutants.expression time. The behavior of the GRV(2Gly) variant
was indistinguishable from WT PrD. In [PSI1] cells, Our studies reveal a critical role for Gln and Asn resi-
dues in stabilization of the amyloid state. First, all of theGRV(-Gly)-GFP showed punctate fluorescence even at
early points in the induction (3 hr), whereas only diffuse mutations cluster to the most Gln/Asn-rich region of the
Sup35p PrD. Second, all of the mutations were foundstaining was observed in [psi2] cells (Figure 7). For
GRV(1Gly), at early times the fluorescent pattern in in Gln or Asn residues, with the exception of a single
Ser and a single Gly. Finally, when present in the context[PSI1] cells appeared diffuse in a significant fraction of
the cells. At later times, however, a uniformly punctate of full-length Sup35p, this region can be replaced by a
polyGln tract while retaining its ability both to form depattern was observed. This indicates that GRV(1Gly)-
GFP was also capable of being recruited in WT aggre- novo amyloids and to be incorporated into preexisting
WT amyloids. These observations argue for the func-gates although with decreased efficiency compared to
GRV(-Gly)-GFP. The behavior of the GRV[polyQ-Gly] and tional equivalence of the various polar residues (Gln,
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Figure 7. Recruitment of GRV Alleles of
Sup35p by WT Aggregates
Yeast expressing GRV-GFP fusion proteins
were examined at the indicated time after in-
duction. The PSI state of the cells and the
expressed GRV allele are as noted. The amino
acid changes, relative to WT, in the various
GRV alleles are indicated in top panel. Amino
acids altered in ASU or PNM mutants are de-
noted by an asterisk.
Asn, and Ser) in this critical region of the Sup35p PrD. A appears to propagate by a prion-like mechanism (Wick-
ner, 1994). The protein responsible for the [URE3] state,possible explanation for the stabilization of the amyloid
state by Gln/Asn residues was suggested by Perutz and Ure2p, is extremely rich in Asn as well as other polar
residues. Furthermore, Ure2p has been reported to formcoworkers, who pointed out that in b sheets carboxy-
amide side chains could form a ªpolar zipperº involving filaments in vitro (King et al., 1997). Perhaps most inter-
estingly, a number of neurodegenerative diseases havea network of side chain±main chain hydrogen bonds
(Stott et al., 1995). recently been found to result from expansion of polyGln
repeats that leads to intracellular aggregates in vivo andIt is likely that Gln- and Asn-rich domains play an
important role in stabilizing a significant subset of amy- amyloids in vitro (see below).
loid phenomena. The putative PrD region of the Sup35p
homolog of Pichia pinus is rich in Asn and Gln, despite Implications for the Prion Hypothesis
The prion hypothesis argues that a protein alone can actthe lack of linear sequence homology with the S.cerevis-
iae gene (Kushnirov et al., 1990). Even more striking as an infectious agent, leading to a permanent change in
the phenotype of the infected organism (Prusiner et al.,is the recently sequenced SUP35 gene from Candida
albicans, which contains z55 Gln residues in its putative 1998). This infectivity is thought to result from an altered
conformation that both causes the phenotypic changePrD domain, including longstretches of pure Gln repeats
near the N terminus. These observations suggest that and promotes conversion of new protein, thereby allowing
self-replication. Studies on themammalian prion proteinthe amino acid composition of a protein, as much as its
exact primary sequence, determines its amyloidogeni- PrP, the yeast prion Sup35p, and nonprion amyloids have
reproduced self-propagating conformational changes incity. Another epigenetic factor in yeast, [URE3], also
Role of Gln/Asn Repeats in a Yeast Prion
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vitro (Glover et al., 1997; Harper and Lansbury, 1997; For example, the molecular chaperone HSP104 is re-
quired for maintenance of the [PSI1] state; paradoxi-King et al., 1997; Paushkin et al., 1997). Connecting
cally, HSP104 also causes loss of [PSI1] when overex-these conformational changes to the phenotypic change,
pressed (Chernoff et al., 1995). We find that the kineticshowever, has proven more elusive. Here, we show that
of conversion are enhanced greatly by the addition ofpure PrD can propagate amyloids on a physiological
a slow rotation step. Similar enhancement in the kineticstime scale in vitro. Moreover, we used a series of point
of polymerization is observed when hemoglobin S ismutants that lead to a loss of the prion-associated phe-
subjected to rotation forces (Briehl, 1980). Given that innotype to test the relevance of the in vitro conversion
the absence of such forces, conversion of Sup35p inreaction. These mutants cause solubilization of protein
vitro is far slower than the doubling time of yeast, it isin vivo and decreased rates of de novo amyloid forma-
an attractive hypothesis that in a growing cell amyloidtion and recruitment into preformed fibrils in vitro. These
fibrils undergo continuous disrupton. As noted by Ter-observations provide perhaps the most compelling data
Avanesyan and coworkers, HSP104 might contribute toto date linking an in vitro conversion reaction to the
such an effect, as it has been shown to break up otherphenotypic change effected by a prion, thus providing
protein aggregates (Paushkin et al., 1996; see, however,strong support for the prion hypothesis.
Patino et al., 1996). Using the in vitro assay, we canThe studies also furnish insights into the mechanism
quantitatively assess theability of HSP104or othercellu-by which the Sup35p prion propagates its altered con-
lar components to increase the number of polymerizingformation. In vitro characterizations of the kinetics of
ends in an amyloid fibril sample.amyloid formation from purified amyloidogenic proteins
A molecular chaperone, termed protein X, has alsoor peptides have suggested that conversion is a nucle-
been implicated in propagation of the prion form of theation-dependent process (Jarrett and Lansbury, 1993;
mammalian PrP protein (Kaneko et al., 1997). The iden-Harper and Lansbury, 1997). In such processes, the lag
tity of protein X is unknown, but its existence has beenphase results from the thermodynamically unfavorable
inferred by the behavior of a number of dominant-nega-formation of competent nuclei and is followed by a con-
tive forms of PrP. Our dominant-negative Sup35p allelesversion phase in which the transition from monomer to
could also result from altered recognition by a molecularfibril occurs in a rapid, cooperative fashion. The nucle-
chaperone such a HSP104. Alternatively, our Sup35p
ation-polymerization model makes several predictions
mutants might form heteropolymers with WT protein
(Jarrett and Lansbury, 1993) that distinguish it from other
that fail to effectively promote conversion of either WT
conversion mechanisms (e.g., the template conversion
or mutant protein. Consistent with this proposal, GFP
model in which the catalyst acts by promoting a rate-
analysis reveals that the mutants can be recruited into
limiting conformational change [Prusiner and al, 1998]).
WT aggregates in vivo. Moreover, in vitro WT and AS17R
First, there is a critical monomer concentration below amyloids are mutually defective in seeding each other's
which no conversion occurs. Second, the length of the conversion.
lag time is highly dependent on the protein concentra-
tion. Finally, the lag phase will approach zero at infinite Implications for the Mechanism of CAG
concentration, and as this limit is approached, addition Repeat±Mediated Pathogenesis: PolyGln
of seed no longer accelerates fiber formation. Diseases as Intracellular Prions?
Here, we tested critically the nucleation-polymeriza- A number of inherited neurodegenerative diseases re-
tion model by examining the kinetics of de novo amyloid sult from expansion of the CAG nucleotide triplet leading
formation of Sup35p. We find that within a range of to the insertion of a polyGln tract at the protein level.
1.25±12 mM theconversion of monomer appears to go to Concurrent with our studies, polyGln insertions were
completion. Thus, thecritical concentration, if it exists, is shown to lead to formation of amyloid fibrils in vitro and
well below micromolar as compared to 10±40 mM for in vivo (e.g., Paulson et al., 1997; Scherzinger et al.,
b-amyloid peptide (Harper and Lansbury, 1997). We also 1997; see, however, Kahlem et al., 1998). This polyGln-
find that the rate of amyloid formation shows only mod- mediated aggregation appears to be intimately associ-
est concentration dependence. In particular, between ated with pathogenesis.
1.25 and 6 mM the rate of spontaneous conversion is Our functional analysis of Sup35p amyloid formation
approximately first order. At concentrations between 6 raises the interesting possibility that [PSI1] and polyGln-
and 12 mM, the lag time has a constant value of z65 min. mediated pathogenesis are related phenomena involv-
Yet this lag phase is completely eliminated by addition of ing intracellular prion-like propagation of amyloid fibrils
as little as 3% (wt/wt) preformed aggregate. It remains stabilized by a polar network of carboxyamide side
possible that at extremely low concentrations, the kinet- chains. There are, however, important differences be-
ics of conversion would be adequately described by tween the aggregation of Sup35p- and polyGln-medi-
the nucleation polymerization model. However, we find ated amyloid formation. Notably, while the total number
dramatic catalysis of fibril formation even at concentra- of Gln/Asn residues in Sup35p is comparable to the
tions where oligomerization is not rate limiting. These number found in the pathogenic repeat disorders, the
data argue that fibrils accelerate the conversion of Gln/Asn tracts in Sup35p are not continuous. There is
Sup35p by promoting a conformational change (e.g., also currently no direct evidence to address whether
conversion of profibrils to fibrils [Harper et al, 1997a]) polyGln amyloids facilitate their own conversion during
rather than solely by providing a multimeric nucleus. pathogenesis. A prediction of the self-replicating amy-
Although pure Sup35p PrD-M forms amyloids rapidly loid model is that a cell will undergo a stochastic conver-
in vitro, a variety of cellular factors are likely to play an sion event, after which newly made protein will be re-
cruited into amyloid fibrils. Consistent with this, weimportant role in propagation of the Sup35p prion state.
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and P6. Diversity in the mutant pool was maintained by keeping 3±6found in a related set of studies that huntingtin protein
separate PCR pools and 3±6 separate transformation pools. Basedcontaining pathogenically expanded polyGln repeats
on the levels of incidental second site mutations as well as sequenc-fused to GFP is initially soluble when expressed in yeast
ing of phenotypically WT PrD alleles, we estimate that z30% of the
but eventually forms aggregates that appear to propa- PCR products contain at least one point mutation. The mutagenized
gate stably (A. S. and J. S. W., unpublished data). We PrD was reintroduced into p316SpSUP-EF by cotransforming [PSI1]
yeast with the linear PCR product and p316SpSUP-EF gapped byare currently using the in vitro assay to directly examine
digestion with BamHI and PflmI. Transformants were selected onthe propagation of huntingtin amyloids.
SD-URA, harvested by washing in TE, and plated at density of 500Regardless of the exact mechanism of propagation,
cells/plate on YPD to test for sectoring. The sectoring colonies wereyeast could providea powerfulgenetic system for study-
patched onto SD-URA, retested for sectoring by growth on YPD,
ing polyGln-mediated amyloid formation. In particular, tested for plasmid-dependent antisuppression by growth on SD-
yeast should facilitate efforts to find extragenic factors URA, ADE, and SD-URA, and tested for curing by growth on SD-
URA supplemented with 5-FOA.involved in the conversion process (e.g., molecular chap-
erones, transglutaminases, or proteolytic processing
GFP Induction/Microscopy and Extract Preparation/Highenzymes). Indeed, as with Sup35p, increased HSP104
Speed Centrifugationlevels slow somewhat the rate of huntingtin aggregation
Yeast carrying p426CpSUP-GFP, p426CpASU/PNM-GFP (11 al-
(A. S. and J. S. W., unpublished data). Finally, by using leles), or p426CpGRV-GFP (4 alleles) were grown to early log phase
yeast it should be possible to rapidly screen for domi- in SD-URA. At the indicated time after induction with 50 mM CuSO4,
nant-negative mutants or small molecules capable of samples were spun down, resuspended in TE and examined by
fluorescence microscopy (Olympus BX60), and photographed byinhibiting the conversion process in vivo.
film or CCD camera (Photometrics).
To prepare extracts, 50 ml cultures of yeast carrying eitherExperimental Procedures
p316SpSUP(HA)3EF, p316SpASU/PNM(HA)3EF, or p315SpSUP(HA)3EF
and p316SpASU/PNM-EF were grown in appropriate selective me-General Procedures and Reagents
dium to mid±log phase and harvested at room temperature. CellIsogenic [PSI1] and [psi2] versions of strain 74D-694 [MATa, ade1,
pellets were washed once in an equal volume of distilled water andhis3, leu2, trp1, ura3; suppressible marker ade1-14(UGA)] were used
resuspended in buffer A (25 mM Tris-HCl [pH 7.5], 50 mM KCl, 10(Chernoff et al., 1995). All nucleic acid and yeast manipulations were
mM MgCl2, 1 mM EDTA, 5% Glycerol, 1 mM PMSF, 2 mg/ml pepstatinperformed according to standard laboratory protocols (Sherman,
and leupeptin, and 100 mg/ml ribonuclease A). Cell pellets were1991; Ausubel et al., 1995). PCR primers were as follows: P1,
resuspended in approximately 2 vol of buffer A, 2 vol of glass beadsGGCCCCCCTCGAGTGAGAGAACCGTTAAATTCCC; P2, CC CCGG
were added, and cells were disrupted by vortexing for 3 min at 48C.ATCCTGCTAGTGGGCAGATATAGAT; P3, GGGAGGCTCGAGCTTC
Centrifugation was performed as described (Patino et al., 1996) withAACGATTTCTATGATTC; P4, GGGGGATCCTAT GTGATGATTGAT
minor modifications. The slurries were spun at 8000 g for 3 min atTGATTG; P5, GCGGGATCCACAATGTCGGATTCAAACCA; P6, CCG
48C to pellet unbroken cells andglass beads; the remaining superna-GCCGAATTCAGATCTATCGTTAAC; P7, CCCCCCAGATCTGAATTC
tant was spun at 100,000 g for 30 min at 48C. Supernatant wasCCATGGATGTTTGGTGGTAAAGATCAC; P8, CCCCCGAGCTCACC
removed, and the pellet was resuspended in an equal volume ofTTGTTTATGGTATATGGT; P9, GGGGGGGCATATGTCGGATTCAAA
cold buffer A. Samples (20 mg of total protein) were analyzed byCCAAGGC; P10, CCGGGACGCGTGAATTCTTAATGGTGGTGATG
SDS-PAGE and Western blot analysis (Ausubel et al., 1995) usingGTGATGGTGATGATGATCGTTAACAACTTCGTCATC-. S. Cerevis-
the 16B12 antibody (Babco) and goat anti-mouse IgG-HRP conju-iae Genomic DNA was used as a PCR template (Stratagene).
gate (Bio-Rad).
Plasmid Construction
PrD-M Expression and PurificationTo facilitate exchange of promoters and protein domains, PCR was
Pure PrD-M was prepared largely as described previously (Gloverused to introduce restriction sites flanking the promoter, the PrD-M
et al., 1997). Briefly, cell pellets from 1±2 l of growth were lysed indomain, and the EF domain of SUP35, generating a set of inter-
30 ml of buffer B (25 mM Tris [pH 7.8], 300 mM NaCl, 6 M urea).changeable cassettes. The promoter cassette was defined by a 59
Subsequent to centrifugation at 25,000 g (20 min), the supernatantXhoI site and a 39 BamH1 site, the PrD-M cassette by a 59 BamH1
was filtered by 0.22 mm filter (Millipore) and applied to 20 ml Ni-NTAsite and 39 BglII and EcoR1 sites, and the EF cassette by a 59 EcoR1
agarose (Qiagen) column. The column was washed with 5 column volsite and a 39 SacI site. Two promoters were used: the endogenous
buffer B and eluted with a pH gradient in same buffer without NaCl.SUP35 promoter (Sp) (P1 and P2) and the CUP1 promoter (Cp) (P3
Pooled fractions were applied to a 30 ml Source 15S column (Phar-and P4). PrD-M domains were generated by P5 and P6. The EF
macia) equilibrated in 50 mM MES [pH 6.0], 6 M urea and eluteddomain was generated using P7 and P8. This domain was ex-
with 0±400 mM NaCl gradient in the same buffer. Pure PrD-M waschanged with GFP where indicated; GFP containing the appropriate
concentrated with centricon-10 (Amicon), filtered by microcon-100sites was derived from pRS316-Pho4-GFP (E. K. O'Shea, personal
(Amicon), aliquoted, and stored at 2808C. Protein concentrationcommunication). Epitope tags were inserted between the M and EF
was determined by UV absorption at 275 nm.domains, using the 59 BglII site and the 39 EcoR1 site. All plasmids
were derived by ligating the insert between the Xho1/Sac1 sites of
the following vectors; pRS316 (low copy CEN/ARS, URA31), Congo Red Binding Assay
Congo red binding assays were carried out largely as describedpRS315 (low copy CEN/ARS, LEU21), and pRS426 (high copy 2
mm, URA31) (Christianson et al., 1992). Constructs are denoted by previously (Klunk et al., 1989). Congo red (Sigma) was dissolved in
buffer C (5 mM potassium phosphate, 150 mM NaCl), filtered withthe plasmid backbone, promoter, PrD allele, and whether the EF or
GFP domain is present (Epitope tags are noted between the PrD-M 0.22 mm filter (Millipore), and adjusted to 100 mM. To initiate conver-
sion, concentrated PrD-M was diluted at least 100-fold into bufferand EF domains where relevant). For bacterial expression, the ap-
propriate allele of PrD-M was amplified using P9 and P10, which C in 2 ml microcentrifuge tubes at room temperature. The solution
was subjected to constant rotation (7.5 rpm) using a RKVS Rotamixintroduces a His tag at the C terminus. These products were sub-
cloned into NdeI/EcoRI sites of a T7 expression vector. The se- (ATR). At indicated times, protein was diluted to 2 mM inthe presence
of 10 mM Congo red in buffer C. Absorbances at 540 and 477 nmquence of all plasmids was confirmed by dye termination sequenc-
ing (Perkin Elmer). were determined (either by Shimadzu UV160U or Aviv 14DS spectro-
photometer). Congo red bound per mole of PrD-M was determined
by the formula (A540/25292)-(A477/46306). Quantitative measurementScreen for ASU and PNM Mutants
The SUP35 PrD was mutagenizedby 30 rounds of PCRamplification of the length of the lag phase (T0) was performed by fitting the middle
of the sigmoidal curves with a straight line and solving the time forwith Taq polymerase using the manufacturer's conditions and P1
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which the amount of Congo red bound is that of baseline. Likewise, protein during scrapie prion propagation. Proc. Natl. Acad. Sci. USA
94, 10069±10074.the length of the conversion phase (Tc) was calculated by subtracting
T0 from the time at which dye binding is maximal. Kelly, J.W., Colon, W., Lai, Z., Lashuel, H.A., McCulloch, J.,
McCutchen, S.L., Miroy, G.J., and Peterson, S.A. (1997). Transthy-
Atomic Force Microscopy retin quaternary and tertiary structural changes facilitate misassem-
Protein samples were absorbed to freshly cleaved mica surface. bly into amyloid. Adv. Protein Chem. 50, 161±181.
AFM images were collected with a NanoScope IIa (Digital Instru- King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., and
ments) operated in contact mode with a commercial NP-S silicon WuÈ thrich, K. (1997). Prion-inducing domain 2-114 of yeast Sup35
nitride tips. protein transforms in vitro into amyloid-like filaments. Proc. Natl.
Acad. Sci. USA 94, 6618±6622.
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